Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) has provided new measures of glycemic control that link to diabetes complications. This study investigated the association between the time in range (TIR) assessed by CGM and diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: A total of 3,262 patients with type 2 diabetes were recruited. TIR was defined as the percentage of time spent within the glucose range of 3.9–10.0 mmol/L during a 24-h period. Measures of glycemic variability (GV) were assessed as well. DR was determined by using fundus photography and graded as 1) non-DR; 2) mild nonproliferative DR (NPDR); 3) moderate NPDR; or 4) vision-threatening DR (VTDR). RESULTS: The overall prevalence of DR was 23.9% (mild NPDR 10.9%, moderate NPDR 6.1%, VTDR 6.9%). Patients with more advanced DR had significantly less TIR and higher measures of GV (all P for trend <0.01). The prevalence of DR on the basis of severity decreased with ascending TIR quartiles (all P for trend <0.001), and the severity of DR was inversely correlated with TIR quartiles (r = −0.147; P < 0.001). Multinomial logistic regression revealed significant associations between TIR and all stages of DR (mild NPDR, P = 0.018; moderate NPDR, P = 0.014; VTDR, P = 0.019) after controlling for age, sex, BMI, diabetes duration, blood pressure, lipid profile, and HbA1c. Further adjustment of GV metrics partially attenuated these associations, although the link between TIR and the presence of any DR remained significant. CONCLUSIONS: TIR assessed by CGM is associated with DR in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic management (57).”
In the citing paper
“These results align with existing literature that emphasizes the clinical benefits of higher TIR, including reduced complications and improved overall health outcomes for individuals with diabetes19,22–24.”
From Impact of digital health interventions on glycemic control and weight management. (2025) · cites this paper as [22]
In the citing paper
“Most recently, the beneficial effects of new medications, such as sodium glucose cotransporter-2 (SGLT-2) agents have helped individuals with type 1 diabetes increase TIR (49-51).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [49]
In the citing paper
“TIR has been found to be strongly associated with the development or progression of diabetic retinopathy and microalbuminuria in type 1 and type 2 DM.16 17”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [17]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 2×
“However, HbA1c is unreliable in patients with anemia, hemoglobinopathies, or iron deficiency, and in patients who are pregnant (7).”
BackgroundSelf-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Cited by
Items 401–500 of 568
Glycemic Variability and Other Risk Factors for Diabetic Retinopathy: A Pilot Case-Control Study
Kulkarni, A. S., Kavitha, K. V., Sarkar, N. S., Purandare, V. B., Bhat, S., Tiwari, S., & Unnikrishnan, A. G. (2022) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_3_21 · Cited by 2
Time-in-range: a promising glycemic control metric for bariatric surgery
Kang, M., & Li, W. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.002 · Cited by 2
Kalra, S., Shaikh, S. S., Priya, G., Baruah, M., Verma, A., Das, A. K., Shah, M., Das, S., Khandelwal, D., Sanyal, D., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01120-z · Cited by 2
Zhang, Y., Han, H., Lv, J., & Chu, L. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0431 · Cited by 1
Prattichizzo, F., & Ceriello, A. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00969-3 · Cited by 1
Clinical characteristics and associated factors of constipation patients with type 2 diabetes
Fang, Y., Chen, J., Ni, C., Dai, Y., Cai, L., Yang, X., Hu, J., & Zhang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1698701 · Cited by 1
Monitorización de la glucemia en DM2
Martin, R. S., & Vela, N. S. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/nuevastecnologias/art1 · Cited by 1
Relationship Between Time in Range and Dusk Phenomenon in Outpatients with Type 2 Diabetes Mellitus
Gao, X., Li, H., Yu, Y., Huai, X., Feng, B., & Song, J. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s410761 · Cited by 1
Liu, W., Cai, D., Zhang, R., Zhang, X., Cai, X., Tao, L., Han, X., Luo, Y., Li, M., Wu, W., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae143 · Cited by 1
Glycemic variability and diabetic cardiac autonomic neuropathy
Serhiyenko, A. A., Tsaryk, T. V., Pavlovskiy, Y., & Serhiyenko, V. A. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.4.2024.1398 · Cited by 1
Dong, L., Li, J., Hu, Y., Chai, R., Zhu, Y. F., Zhu, L., Fan, N., Zhang, Z., Pan, J., Yan, J., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464755 · Cited by 1
Xu, C., Dai, W., Liu, Y., Zhang, R., Shi, E., Shan, X., & Cao, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s498567 · Cited by 1
Li, S., Shan, X., Wei, X., Dai, W., & Cao, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01794-6 · Cited by 1
Xu, J., Gong, Y., Wang, G., & Li, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01911-5 · Cited by 1
Gong, Y., Li, Y., Zhang, Q.-Q., Zhu, Z., & Wang, G. (2025) · Clinical Endocrinology · doi:10.1111/cen.70036 · Cited by 1
Jia Weiping: a clinical scientist creating the “Chinese model” for diabetes prevention and control
Ying, X., Li, H., Gu, Y., Liu, L., & Wu, J. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2026-0024 · Cited by 1
Hivre, M., Holkar, S., Vaishnav, D., & Surkar, P. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.7s.34 · Cited by 1
Underlying cause of diabetic retinopathy: Metabolic instability
Cappellani, F., Capobianco, M., Leonforte, F., Avitabile, A., Visalli, F., Khouyyi, M., Giglio, R., Inferrera, L., Tognetto, D., D’Esposito, F., et al. (2026) · World Journal of Clinical Cases · doi:10.12998/wjcc.v14.i12.120247 · Cited by 1
Li, H., Tao, S., Zhou, X., Yan, R., Yu, B., Luo, Y., Zhang, P., Kong, X., & Ma, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-48843-2 · Cited by 1
Casadei, G., Baldari, M., Brognara, L., Saudelli, E., Moscatiello, S., Flamigni, S., Traina, F., Paccapelo, A., Pagotto, U., & Dalmazi, G. D. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70310 · Cited by 1
Dario, P. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261455365 · Cited by 1
Su, H., Ni, J., Han, W., Cai, J., Zhu, W., Wang, Y., Zhou, J., Lu, J., Ma, X., & Peng, D. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113372 · Cited by 1
Self-citationNi, J., Chen, L., Su, H., Guo, J., Wang, C., Wang, Y., Lu, J., Zhou, J., Xia, T., & Jiang, F. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70260 · Cited by 1
Self-citationCost-Effectiveness of Monitoring Metabolic Control
Smokovski, I. (2020) · Springer eBooks · doi:10.1007/978-3-030-51469-3_5 · Cited by 1
Smartphone-Based Data Collection in Ophthalmology
Raber, F. P., Gerbutavicius, R., Wolf, A., & Kortuem, K. (2020) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1232-4250 · Cited by 1
MERCADO-ASIS, L. B. (2021) · Series of Endocrinology Diabetes and Metabolism · doi:10.54178/jsedmv3i2004 · Cited by 1
Corneal confocal microscopy meets continuous glucose monitoring: a tale of two technologies
Malik, R. A. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002254 · Cited by 1
Zhao, G., Xu, X., Yu, X., Sun, F., Yang, A., Jin, Y., Huang, J., Wei, J., & Gao, B. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02120-0 · Cited by 1
Sakai, M., Kato, T., Ishihara, T., Takao, K., Hirose, T., Kubota, S., Kubota‐Okamoto, S., Imaizumi, T., Takahashi, Y., Mizuno, M., et al. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1590407 · Cited by 1
New Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
Souza, K. L. V. D., Rassi, M. M. B., de Sá, D. A. R., Bussuan, R. M., Rodrigues, L. C. D. S., & Arbex, A. K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.491 · Cited by 1
Mudit, Palukuri, S., & Deka, S. (2022) · British journal of healthcare and medical research · doi:10.14738/jbemi.91.11756 · Cited by 1
The role Time in range depending on the method of assessing glycemic control in diabetes: A review
Суплотова, Л. А., Сергеевна, С. А., & Сергеевна, Д. Т. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.4.201674 · Cited by 1
Relationship of Glycemic Control with Level of Blood Pressure amongst Type 2 Diabetic Patients
Ammarah, S., Jahanzeb, Z., Batool, U., Kauser, S., Muhammad, M., & Mahmood, N. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22167982 · Cited by 1
Jiang, J., Li, Y., Li, F., He, Y. L., Song, L., Wang, K., You, W., Xia, Z., Zuo, Y., Su, X., et al. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2018-4299 · Cited by 1
Manov, A., Nazha, J., Antonio, S., & House, J. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.17.3.0478 · Cited by 1
Insulin Resistance Is an Alternative, Novel Risk Factor for Diabetes-Associated Periodontitis
Shinjo, T., & Zeze, T. (2023) · Current Oral Health Reports · doi:10.1007/s40496-023-00345-0 · Cited by 1
Henao, D. C., Medina, A. M. G., García-Cajiao, A., Robledo, S., Mejía, G., Padilla, S. N. C., Kerguelen, A., Rubio, C., Rondón, M., & Múñoz, Ó. (2023) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.10.3.796 · Cited by 1
Block, C. E. M. D., CHENG, A. Y. Y., Anil, G., D’Cruz, J. M., & Ginovker, A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01603-9 · Cited by 1
Analysis of Clinical Data on the Treatment of Type 2 Diabetes with BMPRP
Liu, B., Gao, X., Chen, Y., Zheng, R., Dong, Q., & Wang, J. (2024) · American Journal of Bioscience and Bioengineering · doi:10.11648/j.bio.20241206.14 · Cited by 1
Bhosle, D. S., Chandekar, B., & Shelke, S. (2025) · Journal of the Association of Physicians of India · doi:10.59556/japi.73.0925 · Cited by 1
Condition assessment of patients with type 1 diabetes using compositional data analysis
Biagi, L. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Cutruzzolà, A., Irace, C., Parise, M., Fiorentino, R., Barone, M., & Gnasso, A. (2020) · doi:10.21203/rs.3.rs-27649/v1 · Cited by 1
The Prediction of DiabetesPreprint
Massaro, A. S., Magaletti, N., Cosoli, G., Giardinelli, V. O. M., & Leogrande, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1753046/v1 · Cited by 1
The Prediction of DiabetesPreprint
Massaro, A. S., Magaletti, N., Cosoli, G., Giardinelli, V. O. M., & Leogrande, A. (2022) · Preprints.org · doi:10.20944/preprints202206.0202.v1 · Cited by 1
The Prediction of DiabetesPreprint
Massaro, A. S., Magaletti, N., Cosoli, G., Giardinelli, V. O. M., & Leogrande, A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4135264 · Cited by 1
Bordács, B. (2025) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12638 · Cited by 1
Colás Herrera, A. M. (2021) · Docta Complutense (Universidad Complutense de Madrid) · Cited by 1
Vastrad, B. M., Pattanashetti, S., Vastrad, C. M., & Bhandi, N. (2026) · Research Square · doi:10.21203/rs.3.rs-8562423/v1 · Cited by 1
Ruiz Gracia, T., Nattero-Chávez, L., Arranz Martín, A., de la Calle de la Villa, E., Lorenzo Moñino, M., Bayona Cebada, A., Corral, M. I., Quintero Tobar, A., Lahera Vargas, M., Jiménez Blanco, S., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113505
Starke Blutzuckerschwankungen — vermehrt Retinopathie
mut (2019) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-019-0046-2
Diabetische Retinopathie bei Patienten mit Diabetes mellitus
Simó‐Servat, O., Hernández, C., & Simó, R. (2019) · Kompass Ophthalmologie · doi:10.1159/000503121
Staltari, B. J., Cutó, F. G., Benkovic, R. I., Loredo, S. D., & Loredo, L. D. (2020) · Alad · doi:10.24875/alad.20000407
Continuous glucose monitoring: Musing on our progress in memory of Dr Andrew Jay Drexler
Grunberger, G. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13032
Soares, B. M. M. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5h1v-zm32
(2021) · The Singapore Family Physician · doi:10.33591/sfp.47.1.uo2
Khan, A., Shaikh, N. A., Alvi, Y., Gupta, P., Mehdi, R., & Siddiqui, A. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117480
Li, X., Yao, L., Wang, X., Zhong, Y., Wang, Y., Wu, J., Geng, J., Zhou, Y., Zhang, J., Chen, J., et al. (2020) · doi:10.21203/rs.3.rs-91509/v1
Epigenetic Remodeling in an IMR-32 Cell Line and Transgenic Mouse Model of Alzheimer's Disease
Baker, M. S. (2014) · Digital Commons (Liberty University)
Horiuchi, T., Adachi, J., Sekiguchi, Y., & KANAMARU, A. (2021) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000519438
Суплотова, Л. А., Сергеевна, С. А., & Романова, Н. В. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-14-96-103
Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
Gonzales, K. M., & Smith, S. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch8
杜, 小. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.122164
Kerekovska, V., Boyadzhieva, M., Zlatarova, Z. I., & Hristozov, K. (2022) · Scripta Scientifica Medica · doi:10.14748/ssm.v0i0.8120
Correlation Between Time In Range And Serum Uric Acid In Type 2 Diabetes Without HyperuricemiaPreprint
Liu, Y., Peng, X., Qiu, C., Zhu, F., & Shao, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1381513/v1
Lu, G., Wang, M., Fox, T., Jiang, P., & Jiang, F. (2022) · Journal of Shanghai Jiaotong University (Science) · doi:10.1007/s12204-022-2439-0
Age-Related Macular Degeneration and Diabetic Retinopathy
Westenskow, P. D., & Ebneter, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4209-6
Time in range: new parameter to evaluate blood glucose control
Flekač, M. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.066
Prattichizzo, F., & Ceriello, A. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00968-4
Hermida, Á. B. Á., & Trébol, F. G. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/nuevastecnologias/art3
Control of Blood Glucose and Cardiovascular Risk Profile
Ciardullo, S., & Perseghin, G. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_28
Pandya, S. J., Pandya, S. J., & Savaliya, C. H. (2023) · Journal of Diabetes Metabolism and its Complications · doi:10.31487/j.jdmc.2022.01.02
Circadian rhythm of glycemic control in patients with mellitus diabetes
Vásquez-Muñoz, M. (2023) · Academica-e (Universidad Pública de Navarra) · doi:10.48035/tesis/2454/44695
Kosteneffektivität der Überwachung der metabolischen Kontrolle
Smokovski, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-27793-1_5
Lei, X., Li, Z., Zhou, Q., Jiao, Y., Qiu, X., Fu, S., & Qiu, C. (2023) · doi:10.37766/inplasy2023.4.0095
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573
Importance of continuous glucose monitoring in the treatment of diabetes mellitus
Moon, S. J., & Lee, W. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.7.432
Continuous Glucose Monitoring for Non-insulin Dependent Diabetics in Naturopathic Clinical Practice
Duizer, D. (2021) · CAND Journal · doi:10.54434/candj.11
Wang, W., Lu, J., Li, J., Ma, Y., Wang, X., Zhang, F., Li, C., Jiang, J., & Hao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3834867/v1
Self-citationNi, Y., Liu, D., Zhang, X., & Qiao, H. Y. (2023) · Frigid Zone Medicine · doi:10.2478/fzm-2023-0031
He, W., Fang, T., Fu, X., Lao, M., & Xiao, X. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03717-1
Alonso, G. T., & Harit, D. (2024) · Indian Pediatrics · doi:10.1007/s13312-024-3105-4
Positioning “Time-in-Range” in the Treatment of Diabetes in India
Mohan, V., Unnikrishnan, A. G., Kesavadev, J., & Saboo, B. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_2_22
Wang, W., Lu, J., Li, J., Ma, Y., Wang, X., Zhang, F., Li, C., Jiang, J., & Hao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4098611/v1
Self-citationGrotta, R. L. (2024) · The Journal of AMD · doi:10.36171/jamd24.27.1.3
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
常, 映. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492600
Suresh, A., Kumar, B., Boopathy, S., & Thangavelu, S. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_469_23
ҮЗДІКСІЗ ГЛИКЕМИЯЛЫҚ МОНИТОРИНГ – ДИАБЕТОЛОГИЯДАҒЫ ЖАҢА ТЕХНОЛОГИЯЛАР (әдеби шолу)
Kaibagarova, I., Мавлюдова, Н. М., Ж.Ж., Н., Овсянникова, А. К., & Kalzhanova, M. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.62.25.006
Basson-Shleymovich, Y., Yahalom-Peri, T., Azmon, M., & Cukierman‐Yaffe, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237089
Hussain, I., MacLeod, J., Dunn, F., Bickel, P. E., Abreu, M., McNulty, N., Lingvay, I., Kermani, A., & Abreu, M. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch03
Saba-Abusada, A., Manrique-Hurtado, H., Angulo, J., Ibárcena, P. M. P., Santisteban, S. N. S., & Leey, J. (2025) · Alad · doi:10.24875/alad.24000020
石, 来. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551562
Prado, F. (2025) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.24000043
Épidémiologie du diabète et de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00001-5
Classification de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00005-2
Formes cliniques — cas particuliers
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00007-6
The Influence of Hyperglycemia on Renin-Angiotensin System Activation in Diabetic Nephropathy
Alsubhi, M. I., Alshammari, S. M., Almutairi, O., Alshammari, A. M., Tuwaymah, A. M. A., Alsedrani, R. H., & Almeteb, S. M. (2025) · doi:10.52533/johs.2025.50601
He, L., Chen, J., Chen, W., & Shen, X. (2025) · Journal of Laboratory Medicine · doi:10.1515/labmed-2025-0017
Continuous glucose monitoring in patients with type 2 diabetes mellitus on oral hypoglycemic therapy
Кузина, И. А., Акрамовна, Э. Э., & Petunina, N. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-414
Fan, N., Xu, H., Zhu, L., Zhu, Y., Dong, L., Wang, P., Chen, S., Yang, J., Zheng, X., Hu, Y., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7932961/v1
Metadata
- Authors
- Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Zhou, Jian
- Jia, Weiping
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-09-10
- Volume
- 41
- Issue
- 11
- Pages
- 2370-2376
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2891930016
- Cited by
- 517
- References
- 32
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 87 · 2021: 85 · 2020: 71 · 2019: 40 · 2018: 1
- FWCI
- 39.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100590)
- Shanghai Municipal Education Commission (20161430)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, continuous glucose monitoring, diabetic retinopathy, type 2 diabetes, glycemic variability, glycemic control, non-proliferative diabetic retinopathy, vision-threatening diabetic retinopathy, retinopathy severity
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Reference Values, Retrospective Studies, Time Factors, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.